Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII

Cell Reports

Volumn 12, Issue 8, 2015, Pages 1252-1260

  Antal, Corina E ^a   Callender, Julia A ^a   Kornev, Alexandr P ^a   Taylor, Susan S ^a   Newton, Alexandra C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C BETA; PROTEIN KINASE C BETA II; UNCLASSIFIED DRUG; CALCIUM;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; INTRAMOLECULAR C2 DOMAIN; MOLECULAR DOCKING; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS CELL LINE; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CERCOPITHECUS AETHIOPS; COS CELLS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN KINASE C BETA; PROTEIN STRUCTURE, TERTIARY;

EID: 84939787815     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.07.039     Document Type: Article

References (53)

1. Antal C.E., Violin J.D., Kunkel M.T., Skovsø S., Newton A.C. Intramolecular conformational changes optimize protein kinase C signaling. Chem. Biol. 2014, 21:459-469.
2. Antal C.E., Hudson A.M., Kang E., Zanca C., Wirth C., Stephenson N.L., Trotter E.W., Gallegos L.L., Miller C.J., Furnari F.B., et al. Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor. Cell 2015, 160:489-502.
3. Banci L., Cavallaro G., Kheifets V., Mochly-Rosen D. Molecular dynamics characterization of the C2 domain of protein kinase Cbeta. J. Biol. Chem. 2002, 277:12988-12997.
4. Belin R.J., Sumandea M.P., Allen E.J., Schoenfelt K., Wang H., Solaro R.J., de Tombe P.P. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ. Res. 2007, 101:195-204.
5. Bernadó P. Effect of interdomain dynamics on the structure determination of modular proteins by small-angle scattering. Eur. Biophys. J. 2010, 39:769-780.
6. Bowling N., Walsh R.A., Song G., Estridge T., Sandusky G.E., Fouts R.L., Mintze K., Pickard T., Roden R., Bristow M.R., et al. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 1999, 99:384-391.
7. Conrad R., Keranen L.M., Ellington A.D., Newton A.C. Isozyme-specific inhibition of protein kinase C by RNA aptamers. J. Biol. Chem. 1994, 269:32051-32054.
8. Corbalán-García S., García-García J., Rodríguez-Alfaro J.A., Gómez-Fernández J.C. A new phosphatidylinositol 4,5-bisphosphate-binding site located in the C2 domain of protein kinase Calpha. J. Biol. Chem. 2003, 278:4972-4980.
9. Dries D.R., Gallegos L.L., Newton A.C. A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. J. Biol. Chem. 2007, 282:826-830.
10. Dutil E.M., Newton A.C. Dual role of pseudosubstrate in the coordinated regulation of protein kinase C by phosphorylation and diacylglycerol. J. Biol. Chem. 2000, 275:10697-10701.
11. Dutil E.M., Toker A., Newton A.C. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol. 1998, 8:1366-1375.
12. Edwards A.S., Newton A.C. Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C. J. Biol. Chem. 1997, 272:18382-18390.
13. Edwards A.S., Newton A.C. Regulation of protein kinase C betaII by its C2 domain. Biochemistry 1997, 36:15615-15623.
14. Feng X., Becker K.P., Stribling S.D., Peters K.G., Hannun Y.A. Regulation of receptor-mediated protein kinase C membrane trafficking by autophosphorylation. J. Biol. Chem. 2000, 275:17024-17034.
15. Gallegos L.L., Kunkel M.T., Newton A.C. Targeting protein kinase C activity reporter to discrete intracellular regions reveals spatiotemporal differences in agonist-dependent signaling. J. Biol. Chem. 2006, 281:30947-30956.
16. Giorgione J., Hysell M., Harvey D.F., Newton A.C. Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C. Biochemistry 2003, 42:11194-11202.
17. Gould C.M., Antal C.E., Reyes G., Kunkel M.T., Adams R.A., Ziyar A., Riveros T., Newton A.C. Active site inhibitors protect protein kinase C from dephosphorylation and stabilize its mature form. J. Biol. Chem. 2011, 286:28922-28930.
18. Grodsky N., Li Y., Bouzida D., Love R., Jensen J., Nodes B., Nonomiya J., Grant S. Structure of the catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor. Biochemistry 2006, 45:13970-13981.
19. Guerrero-Valero M., Ferrer-Orta C., Querol-Audí J., Marin-Vicente C., Fita I., Gómez-Fernández J.C., Verdaguer N., Corbalán-García S. Structural and mechanistic insights into the association of PKCalpha-C2 domain to PtdIns(4,5)P2. Proc. Natl. Acad. Sci. USA 2009, 106:6603-6607.
20. Hannun Y.A., Bell R.M. Phorbol ester binding and activation of protein kinase C on triton X-100 mixed micelles containing phosphatidylserine. J. Biol. Chem. 1986, 261:9341-9347.
21. Hannun Y.A., Loomis C.R., Bell R.M. Activation of protein kinase C by Triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine. J. Biol. Chem. 1985, 260:10039-10043.
22. Hommel U., Zurini M., Luyten M. Solution structure of a cysteine rich domain of rat protein kinase C. Nat. Struct. Biol. 1994, 1:383-387.
23. Ji J., Hassler M.L., Shimobayashi E., Paka N., Streit R., Kapfhammer J.P. Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14. Neurobiol. Dis. 2014, 70:1-11.
24. Keranen L.M., Newton A.C. Ca2+ differentially regulates conventional protein kinase Cs' membrane interaction and activation. J. Biol. Chem. 1997, 272:25959-25967.
25. Kheifets V., Mochly-Rosen D. Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol. Res. 2007, 55:467-476.
26. Kikkawa U., Takai Y., Tanaka Y., Miyake R., Nishizuka Y. Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem. 1983, 258:11442-11445.
27. Kishimoto A., Kajikawa N., Shiota M., Nishizuka Y. Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J. Biol. Chem. 1983, 258:1156-1164.
28. König B., DiNitto P.A., Blumberg P.M. Stoichiometric binding of diacylglycerol to the phorbol ester receptor. J. Cell. Biochem. 1985, 29:37-44.
29. Leonard T.A., Róz˙ycki B., Saidi L.F., Hummer G., Hurley J.H. Crystal structure and allosteric activation of protein kinase C βII. Cell 2011, 144:55-66.
30. Moore P.B. Small-angle scattering: information content and error analysis. J. Appl. Crystallogr. 1980, 13:168-175.
31. Nalefski E.A., Falke J.J. The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci. 1996, 5:2375-2390.
32. Nalefski E.A., Newton A.C. Membrane binding kinetics of protein kinase C betaII mediated by the C2 domain. Biochemistry 2001, 40:13216-13229.
33. Orr J.W., Newton A.C. Intrapeptide regulation of protein kinase C. J. Biol. Chem. 1994, 269:8383-8387.
34. Orr J.W., Keranen L.M., Newton A.C. Reversible exposure of the pseudosubstrate domain of protein kinase C by phosphatidylserine and diacylglycerol. J. Biol. Chem. 1992, 267:15263-15266.
35. Parissenti A.M., Kirwan A.F., Kim S.A., Colantonio C.M., Schimmer B.P. Inhibitory properties of the regulatory domains of human protein kinase Calpha and mouse protein kinase Cepsilon. J. Biol. Chem. 1998, 273:8940-8945.
36. Parker P.J., Murray-Rust J. PKC at a glance. J. Cell Sci. 2004, 117:131-132.
37. Quest A.F., Bell R.M. The regulatory region of protein kinase C gamma. Studies of phorbol ester binding to individual and combined functional segments expressed as glutathione S-transferase fusion proteins indicate a complex mechanism of regulation by phospholipids, phorbol esters, and divalent cations. J. Biol. Chem. 1994, 269:20000-20012.
38. Reyland M.E. Protein kinase Cdelta and apoptosis. Biochem. Soc. Trans. 2007, 35:1001-1004.
39. Riedel H., Su L., Hansen H. Yeast phenotype classifies mammalian protein kinase C cDNA mutants. Mol. Cell. Biol. 1993, 13:4728-4735.
40. Rogers T.B., Inesi G., Wade R., Lederer W.J. Use of thapsigargin to study Ca2+ homeostasis in cardiac cells. Biosci. Rep. 1995, 15:341-349.
41. Rotenberg S.A., Zhu J., Hansen H., Li X.D., Sun X.G., Michels C.A., Riedel H. Deletion analysis of protein kinase Calpha reveals a novel regulatory segment. J. Biochem. 1998, 124:756-763.
42. Scott A.M., Antal C.E., Newton A.C. Electrostatic and hydrophobic interactions differentially tune membrane binding kinetics of the C2 domain of protein kinase Cα. J. Biol. Chem. 2013, 288:16905-16915.
43. Shi F., Telesco S.E., Liu Y., Radhakrishnan R., Lemmon M.A. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proc. Natl. Acad. Sci. USA 2010, 107:7692-7697.
44. Sieber F.E., Traystman R.J., Brown P.R., Martin L.J. Protein kinase C expression and activity after global incomplete cerebral ischemia in dogs. Stroke 1998, 29:1445-1452. discussion 1452-1453.
45. Solodukhin A.S., Kretsinger R.H., Sando J.J. Initial three-dimensional reconstructions of protein kinase C delta from two-dimensional crystals on lipid monolayers. Cell. Signal. 2007, 19:2035-2045.
46. Stensman H., Larsson C. Identification of acidic amino acid residues in the protein kinase C alpha V5 domain that contribute to its insensitivity to diacylglycerol. J. Biol. Chem. 2007, 282:28627-28638.
47. Stensman H., Raghunath A., Larsson C. Autophosphorylation suppresses whereas kinase inhibition augments the translocation of protein kinase Calpha in response to diacylglycerol. J. Biol. Chem. 2004, 279:40576-40583.
48. Takeishi Y., Ping P., Bolli R., Kirkpatrick D.L., Hoit B.D., Walsh R.A. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ. Res. 2000, 86:1218-1223.
49. Verbeek D.S., Knight M.A., Harmison G.G., Fischbeck K.H., Howell B.W. Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting. Brain 2005, 128:436-442.
50. Verdaguer N., Corbalan-Garcia S., Ochoa W.F., Fita I., Gómez-Fernández J.C. Ca(2+) bridges the C2 membrane-binding domain of protein kinase Calpha directly to phosphatidylserine. EMBO J. 1999, 18:6329-6338.
51. Violin J.D., Zhang J., Tsien R.Y., Newton A.C. A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J. Cell Biol. 2003, 161:899-909.
52. Yang J., Kennedy E.J., Wu J., Deal M.S., Pennypacker J., Ghosh G., Taylor S.S. Contribution of non-catalytic core residues to activity and regulation in protein kinase A. J. Biol. Chem. 2009, 284:6241-6248.
53. Young S., Rothbard J., Parker P.J. A monoclonal antibody recognising the site of limited proteolysis of protein kinase C. Inhibition of down-regulation in vivo. Eur. J. Biochem. 1988, 173:247-252.